Irakasgai-zerrenda

Tema 1. Presentación del curso. Objetivos que se persiguen. Profesorado integrante y sus líneas de investigación. Programa y calendario. Metodología docente. Evaluación.



Tema 2. Homeostasis orgánica de los lípidos y patologías asociadas a su desregulación. El hígado y el metabolismo de glicerolípidos y colesterol. La secreción biliar.



Tema 3. Bases moleculares y celulares de las patologías lipoproteicas. Enfermedad de hígado graso y aterosclerosis. Procesos metabólicos alterados y generación intracelular de almacén lipidico.



Tema 4. Esfingolípidos y glicerolípidos bioactivos. Papel en el establecimiento y progreso de patologías inflamatorias y tumorales. Generación intracelular de esfingolípidos y su metabolismo. Rutas de señalización en las que participan.



Tema 5. Señalización celular en enfermedades hepáticas. Principales rutas de señalización implicadas en la generación de carcinoma hepatocelular. Nuevas dianas terapéuticas.



Tema 6. Estrés oxidativo y peroxidación. Especies reactivas oxigenadas y sistemas celulares de protección. Ácidos grasos poliinsaturados. Micronutrientes y balance redox.



Tema 7. Papel del sistema inmune en la progresión de la enfermedad hepática y generación de la cirrosis. Implicación de las células NK. Papel de la osteopontina. Activación de vías de señalización implicadas.



Tema 8. Avances metodológicos implicados en el diagnóstico y pronóstico de enfermedades. La lipidómica y la metabolómica

Bibliografia

Oinarrizko bibliografia

Cellular lipidomics. G van Meer. EMBO J. 24: 3159-3165, 2005

Biochemistry of Lipids, Lipoproteins and Membranes (4th ed.) Vance, D.E. & Vance, J. (2002) Elsevier Science Publishers B.V., Ámsterdam

Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk. E. Ros. Atherosclerosis, 151: 357-379, 2000.

Enfermedades del metabolismo de los lípidos. F. Sánchez de Medina, en Patología Molecular, González de Buitrago-Medina, McGraw Hill-Interamericana 2001.

S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease. Martínez-Uña M, Varela-Rey M, Mestre D, Fernández-Ares L, Fresnedo O, Fernandez-Ramos D, Juan VG, Martin-Guerrero I, García-Orad A, Luka Z, Wagner C, Lu SC, García-Monzón C, Finnell RH, Aurrekoetxea I, Buqué X, Martínez-Chantar ML, Mato JM, Aspichueta P. J Hepatol. 2015 Mar;62(3):673-81

Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Barbier-Torres L, Delgado TC, García-Rodríguez JL, Zubiete-Franco I, Fernández-Ramos D, Buqué X, Cano A, Gutiérrez-de Juan V, Fernández-Domínguez I, Lopitz-Otsoa F, Fernández-Tussy P, Boix L, Bruix J, Villa E, Castro A, Lu SC, Aspichueta P, Xirodimas D, Varela-Rey M, Mato JM, Beraza N, Martínez-Chantar ML.

Involvement of lipid droplets in hepatic responses to lipopolysaccharide treatment in mice. Arisqueta L, Nuñez-Garcia M, Ogando J, Garcia-Arcos I, Ochoa B, Aspichueta P, Fresnedo O, Rueda Y. Biochim Biophys Acta. 2013 Aug;1831(8):1357-67

Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Martínez-Uña M, Varela-Rey M, Cano A, Fernández-Ares L, Beraza N, Aurrekoetxea I, Martínez-Arranz I, García-Rodríguez JL, Buqué X, Mestre D, Luka Z, Wagner C, Alonso C, Finnell RH, Lu SC, Martínez-Chantar ML, Aspichueta P, Mato JM. Hepatology. 2013 Oct;58(4):1296-305.

Anatomical distribution of lipids in human brain cortex by imaging mass spectrometry.

Veloso A, Astigarraga E, Barreda-Gómez G, Manuel I, Ferrer I, Giralt MT, Ochoa B, Fresnedo O, Rodríguez-Puertas R, Fernández JA. J Am Soc Mass Spectrom. 2011 Feb;22(2):329-38. doi: 10.1007/s13361-010-0024-5. Epub 2011 Jan 28.

Distribution of lipids in human brain. Veloso A, Fernández R, Astigarraga E, Barreda-Gómez G, Manuel I, Giralt MT, Ferrer I, Ochoa B, Rodríguez-Puertas R, Fernández JA.

Lipid oxidation inhibitory effects and phenolic composition of aqueous extracts from medicinal plants of colombian amazonia. Lizcano LJ, Viloria-Bernal M, Vicente F, Berrueta LA, Gallo B, Martínez-Cañamero M, Ruiz-Larrea MB, Ruiz-Sanz JI. Int J Mol Sci. 2012;13(5):5454-67.

Phosphatidic acid inhibits ceramide 1-phosphate-stimulated macrophage migration.

Ouro A, Arana L, Rivera IG, Ordoñez M, Gomez-Larrauri A, Presa N, Simón J, Trueba M, Gangoiti P, Bittman R, Gomez-Muñoz A. Biochem Pharmacol. 2014 Dec 15;92(4):642-50.

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. W Khovidhunkit, MS Kim, RA Memon, JK Shigenaga, AH Moser, KR Feingold, C Grunfeld J. Lipid Res., 45: 1169-1196, 2004.

Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm. AD Sniderman, X.L. Zhang, K. Cianflone. Atherosclerosis, 148: 215-229, 2000.

Nuclear receptors and the control of metabolism. GA Francis, E Fayard, F Picard, J Auwerx. Annu. Rev. Physiol.., 65: 261-311, 2003.

Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. B.P. Neve, J.C. Fruchart, B. Staels. Biochem. Pharmacol., 60: 1245-1250, 2000.

The SREBP pathway: regulation of colesterol metabolism by proteolysis of a membrane bound transcription factor. M.S. Brown, J.L. Goldstein. Cell, 89: 331-340, 1997.

Mato JM, Corrales FJ, Lu SC, Avila MA. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J 2002; 16:15-26.

Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: Implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 2001; 34:694-706

Santamaría E, Avila MA, Latasa MU, Rubio A, Martín-Duce A, Lu SC, Mato JM, Corrales FJ. Functional proteomics of non-alcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci USA 2003; 100: 3065-70

Role of Sp1 in insulin regulation of gene expresión. Sampson SL-A, Wong NCW. J Mol Endocrinol 2002; 29: 265-279

AMP-activated protein kinase: the energy charge hypothesis revisited. Hardie DG, Hawley SA. BioEssays 2001; 23: 1112-1119

HuR and mRNA stability. Brennan CM, Steitz JA. Cell Mol Life Sci 2001;58:266-277

Lipids, lipid rafts and caveolae: Their importance for GPCR signaling and their centrality to the endocannabinoid system Judy Barnett-Norris, Diane Lynch, Patricia H. Reggio Life Sciences 77 (2005) 1625¿1639

Serpentine receptors and STAT activation: more than one way to twin a STAT. TIBS on line, Sept 1999

Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases. Arne Östman and Frank-D. Böhmer TRENDS in Cell Biology Vol.11 No.6 June 2001

Regulation of protein kinase cascades by protein phosphatase 2A. TA. Millward, S

Zolnierowicz and BA. Hemmings TIBS 2004176-191

Nitric oxide, ceramide and sphingomyelinase-coupled receptors: A tale of enzymes and messengers coordinating cell death, survival and differentiation. C Perrottaa, C De Palma, S Falconec, C Sciorati, E Clement, Life Sciences 77 (2005) 1732¿1739

G-protein-coupled receptors and signaling networks: emerging paradigms, MJ Marinissen and JS Gutkind. TIPS 22 369-398 2001

The JNK signal transduction pathway, CR Weston and RJ Davis Current Opinion in Genetics & Development 2002, 12:14¿21

Calcium-mediated cellular signals: a story of failures. E Carafoli. TIBS.29 2004

Signal-activated phospholipases. Liscovitch, M. (1994)..(1st ed.). R.G. Lande Company. Austin, TX.

Sphingosine-1-phosphate: an enigmatic signalling lipid. Spiegel, S., and S. Milstien. Na.t Rev. Mo.l Cell Biol. 4: 397-407 (2003).

Modulation of cell signaling by ceramides. Gómez-Muñoz, A. Biochim. Biophys. Acta 1391, 92-109 (1998)

Signal Transduction (2nd Ed). Gomperts, B.D., Kramer, I.M., Tatham, P.E.R. (2003). Academic Press. Elsevier Science, Orlando, FL, USA

Sphingolipids in inflammation: roles and implications. Pettus BJ, Chalfant CE, Hannun YA Curr Mol Med. 4(4):405-18 (2004).

Acid sphingomyelinase in macrophage apoptosis. U.P. Steinbrecher, A. Gómez-Muñoz, V. Duronio. Curr. Opin. Lipidol 15, 531-537 (2004)

Ceramide-1-phosphate: a novel regulator of cell activation, A. Gómez-Muñoz.FEBS Lett. 562 (1-3), 5-10 (2004)

Ceramide-1-phosphate promotes cell survival through activation of the phosphatidylinositol 3-kinase / Protein kinase B pathway. A. Gómez-Muñoz, J. Y. Kong, K. Parhar, S.W. Wang, P. Gangoiti, M. Gonzalez, S. Eivemark, B. Salh, V. Duronio, and U.P. Steinbrecher. FEBS Lett. 579, 3744-3750 (2005).

Oxidants and antioxidants in atherogenesis: an appraisal. S. Parthasarathy, N. Santanam, S. Ramachandran, O. Meilhac. J. Lipid Res., 40: 2143-2157, 1999.

Free radicals in Biology and Medicine. B Halliwell and JMC Gutteridge (eds) (1991). Clarendon Press. Oxford, Great Britain.

Biological Oxidants and Antioxidants: Molecular mechanisms and health effects. L. Packer and A.S.H. Ong (eds.) 1998. AOCS Press.

Oxygen Radicals in Biological Systems. L.Packer (ed.) Methods in Enzymology. Vol 233 (1994). Academic Press.

Oxidants and Antioxidants. L.Packer (ed.) Methods in Enzymology. Vol 299 (1999). Academic Press.

The pathophysiology of mitochondrial cell death. D.R. Green, G. Kroemer. Science, 305, 626-629, 2004.

Lipid Analysis (3rd edition). (Christie, W.W. Oily Press, Bridgwater) (2003).